BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 164 filers reported holding BLUEBIRD BIO INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $22,010 | -53.0% | 22,363 | -38.9% | 0.00% | -50.0% |
| Q1 2024 | $46,822 | +168.3% | 36,580 | +189.2% | 0.01% | +100.0% |
| Q4 2023 | $17,453 | +109.0% | 12,647 | +360.4% | 0.00% | +50.0% |
| Q3 2023 | $8,351 | +81.9% | 2,747 | +96.9% | 0.00% | +100.0% |
| Q2 2023 | $4,590 | +3.5% | 1,395 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $4,436 | -23.9% | 1,395 | +65.7% | 0.00% | 0.0% |
| Q4 2022 | $5,827 | +16.5% | 842 | +16.6% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | – | 722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,964,000 | $59,215,000 | 1.36% |
| Birchview Capital, LP | 75,500 | $2,276,000 | 1.35% |
| Camber Capital Management LP | 1,000,000 | $30,150,000 | 1.04% |
| Sessa Capital IM, L.P. | 875,000 | $26,381,000 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $16,226,000 | 0.92% |
| Tarsadia Capital, LLC | 100,000 | $3,015,000 | 0.81% |
| Bullseye Asset Management LLC | 67,872 | $2,046,000 | 0.76% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,304,246 | $39,323,000 | 0.58% |
| MANGROVE PARTNERS IM, LLC | 175,178 | $5,282,000 | 0.53% |
| Parametrica Management Ltd | 37,712 | $1,080,000 | 0.52% |